RAPAMYCIN FORMULATIONS AND METHODS OF THEIR USE

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20170266109A1
SERIAL NO

15611701

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described herein are liquid rapamycin formulations. Described herein are methods of treating or preventing diseases or conditions, such as choroidal neovascularization, wet AMD and dry AMD, and preventing transition of dry AMD to wet AMD, using the liquid rapamycin formulations described herein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANTEN PHARMACEUTICAL CO LTDOSAKA JAPAN OSAKA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
DOR, Philippe JM Kirkland, US 18 464
FAROOQ, Sidiq Newark, US 13 436
MUDUMBA, Sreenivasu Union City, US 30 1057
NIVAGGIOLI, Thierry Atherton, US 82 2678
WEBER, David A Danville, US 52 2316

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation